• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Industrials·PWN.AX
Share

Parkway Corporate Limited Stocks

A$ 0.01Last Updated 27.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

A$ 15.63M

A$ 0.01
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Parkway Corporate Limited is an Australian cleantech enterprise focused on delivering comprehensive water treatment solutions. The company operates through three distinct segments: Parkway Process Solutions, Parkway Process Technologies, and Parkway Ventures. Through its technology and solutions divisions, Parkway supplies a broad spectrum of products. These encompass specialized analytical instruments for assessing water treatment parameters, a full range of laboratory equipment including glassware and consumables such as syringes and test tubes, and diverse water treatment systems. The company also provides an extensive selection of pumps, from chemical dosing to high-pressure and submersible models, alongside their requisite parts and accessories. Additional offerings include advanced instrumentation and controllers for monitoring, measuring, and automating water treatment processes; piping, hoses, and fittings; various valves and solenoids; filtration and membrane technologies; and robust industrial tanks designed for high-value water treatment applications. Furthermore, Parkway provides an array of water treatment chemicals and advanced disinfection products utilizing methods like chemical disinfection, chlorination, ozone, and UV, complete with related components. Beyond product supply, Parkway offers a suite of professional services. These include analytical testing, comprehensive project evaluations, process development, detailed project engineering, full installation, expert project management, and ongoing operation and maintenance support. In its ventures division, Parkway holds a stake in the Karinga Lakes potash project located in Australia's Northern Territory and manages a proprietary portfolio of industrial wastewater treatment technologies. The company, initially incorporated in 2010 and headquartered in Sunshine North, Australia, adopted its current name, Parkway Corporate Limited, in September 2021, having previously operated as Parkway Minerals NL.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, trading

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.10.2026 08:01

"Too Big a Chicken": McDonald's Partners Deem the New Menu a Failure

28.10.2026 07:01

Healthcare stocks have become a bet against AI. Should you buy them?

28.10.2026 03:18

"The conditions for a rebound are ripe": Stocks rise for a second day ahead of big tech earnings reports

28.10.2026 03:13

Oracle is expanding its partnership with OpenAI and integrating Google chips into its infrastructure

28.10.2026 00:20

Memory stocks cool off in 2H26 amid AI spending doubts

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026